Sector Chart Valneva SE London S.E.

Stocks

0OB3

FR0004056851

Biotechnology & Medical Research

Market Closed - London S.E. 03:03:24 2026-05-14 EDT			5-day change	1st Jan Change
2.592 ^EUR	-38.30%		+7.35%	-30.05%

08-14	Pfizer and Valneva Se Announce European Medicines Agency Validation of Marketing Authorization Application for Lyme Disease Vaccine Candidate	CI
08-14	Pfizer Inc. and Valneva Se Enter Strategic Alliance for Co-Development of Lyme Disease Vaccine Candidate	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes